+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Innovations in Drug Delivery, Cancer Immunotherapies, Biomarker Identification, and Gene Therapy for Preventing Vision Loss

  • ID: 4618118
  • Report
  • Region: Global
  • 15 Pages
  • Frost & Sullivan
1 of 2

This Genetic Technology TOE depicts life sciences trends across drug delivery platforms, cancer immunotherapies, biomarker identification, and gene therapy. Among the therapeutic areas in focus, age-related macular degeneration (AMD), aggressive childhood cancers, and bladder cancer, are of note. Clinical trial analysis of recombinant drugs for different forms of cancer is also presented. The Genetic Technology TechVision Opportunity Engine (TOE) presents the latest R&D developments and advances with an emphasis on opportunities to profit in the explosive field of genetic technology through technology transfer, joint ventures, and acquisitions. The complete gamut of genetic technology applications is covered including the latest developments in omics technologies; genetic, cellular, and alternative therapies; sequencing technologies; and genetically altered animals and plants. The Health & Wellness cluster tracks developments in a myriad of areas including genetic engineering, regenerative medicine, drug discovery and development, nanomedicine, nutrition, cosmetic procedures, pain and disease management and therapies, drug delivery, personalized medicine, and smart healthcare.

Note: Product cover images may vary from those shown
2 of 2

1. Recent Advancements in Development of Novel Drug Delivery Systems, Immunotherapies for Pediatric Cancers, Biomarker identification for Bladder Cancer, and Gene Therapy for preventing Vision loss

  • Advancements in Mode of Drug Delivery for Age-related Macular Degeneration
  • Immunotherapy Developments for Aggressive Childhood Cancers
  • Novel Biomarkers for p53-like Subtype of Bladder Cancer
  • Novel Gene Therapy Construct that Halts Vision Loss

2. Clinical Trial Analysis and Key Contacts

  • Clinical Trial Analysis of Recombinant Drugs for Different Forms of Cancer
  • Key Contacts
Note: Product cover images may vary from those shown
3 of 2

Loading
LOADING...

Order Online - visit: https://www.researchandmarkets.com/reports/4618118
Adroll
adroll